Colgate-Palmolive India (COLPAL) 1877

Size: px
Start display at page:

Download "Colgate-Palmolive India (COLPAL) 1877"

Transcription

1 Result Update Rating matrix Rating : Hold Target : 1919 Target Period : 12 months Potential Upside : 2% What s changed? Target Changed from 1672 to 1919 EPS FY15E Changed from 41.7 to 41.3 EPS FY16E Changed from 47.8 to 47.9 EPS FY17E Introduced 54.8 Rating Unchanged Quarterly performance Q2FY15 Q2FY14 YoY (%) Q1FY15 QoQ (%) Sales EBITDA EBITDA (%) bps bps PAT Key financials Crore FY14 FY15 FY16E FY17E Net Sales 3, ,79.8 4,74.8 5,45.6 EBITDA ,93. PAT EPS ( ) Adj. EPS ( ) Valuation summary FY14 FY15 FY16E FY17E P/E Target P/E Div. Yield Mcap/Sales RoNW (%) RoCE (%) Stock data Particular Amount Market Capitalization ( Crore) 25,525.9 Total Debt (FY14) ( Crore). Cash and Investments (FY14) ( Crore) 287. EV ( Crore) 25, week H/L 187 / 119 Equity capital 13.6 Crore Face value 1 Price performance 1M 3M 6M 12M Colgate Dabur HUL Gillette Analyst Sanjay Manyal sanjay.manyal@icicisecurities.com Parineeta Rajgarhia parineeta.rajgarhia@icicisecurities.com Volume recovers, margin expands November 1, 214 Colgate-Palmolive India (COLPAL) 1877 Colgate Palmolive s Q2FY15 numbers were marginally below our estimate on both sales & earnings front. Net sales grew 1.9% to crore (I-direct estimate: crore) led by strong 7% volume growth in toothpaste Operating margins increased 24 bps to 18.6% mainly on account of softening raw material cost & overhead expenses despite a sharp increase in marketing cost Market share (January-September 214) in toothpaste rose to 56.7% vs. 55.9% YoY while in toothbrush it was up to 42.6% vs. 41.5% YoY Market share continues to strengthen! Colgate Palmolive (CPIL) is the largest player in the oral care segment in India with the market share (June, 214) of 57% in toothpaste and 42.6% in toothbrush category. In spite of Procter & Gamble s (P&G) re-entry into the toothpaste segment in India in June, 213 (brand: Oral B), CPIL s market share has only strengthened. CPIL has increased its market share in toothpaste from 54.7% in June, 212 to 57.1% in April, 214. Similarly, the market share in toothbrush has also increased from 38.7% to 42.3% for the same period. We believe the second largest player in the toothpaste category, HUL, is losing its market share with Dabur India inching share from ~1% to ~11% in last two years. Further, regional players like Vicco, Ajanta, Anchor, Smyle and Baidyanath have also witnessed a loss in market share in toothpastes. The combined share of all these regional brands has slipped to ~2% (213) from more than 5% two years ago and ~ 15% share 1 years back. Advertisement & promotions continue to ride higher In the last two years, Colgate has been very aggressive in its A&P activity especially after P&G s launch of Oral-B toothpaste and GSK consumer expanding its market presence in the sensitive toothpaste category. The A&P expenditure for Colgate has increased to 19.4% of sales in FY14 and 2% in Q2FY15 from 15-16% earlier. We expect the company to maintain a higher A&P expense to maintain its market share and push new launches. We have modelled A&P expenses of 19% in FY15E and 18% of sales in FY16E and FY17E, respectively. Innovations at forefront Over the years, Colgate has built an extensive oral care portfolio through constant innovation, thereby offering products across the value pyramid and within each sub-category (sensitive toothpaste, gum care toothpaste, electric brush, kids brush, etc). Lately, it has been aggressive on extension of its premium portfolio to capture the up-trading consumers. In FY14, it launched two varieties of toothpastes (Active healthy White, Max Fresh Tea) and Slim Soft Toothbrushes. In June, 214 CPIL launched Max Protection Plus Sugar Acid Neutralizer toothpaste. Hence, with constant innovations and higher A&P spends, we believe Colgate would continue to remain the dominant player and be the largest beneficiary of increasing penetration levels in the country (currently at ~75%). Earnings growth to remain healthy; maintain HOLD Led by CPIL s constant effort to innovate its portfolio and drive premiumisation in oral care, we expect margins to improve to 19.9% by FY17E aiding healthy profitability growth of 11.4% CAGR (FY14-17E). We value the stock on triangulated valuation method (DCF, EV/EBITDA and price/sales) and arrive at a target price of 1919/share. ICICI Securities Ltd Retail Equity Research

2 Variance analysis Q2FY15 Q2FY15E Q2FY14 YoY (%) Q1FY15 QoQ (%) Comments Net Sales , Revenues witnessed 1.9% growth led by 7% volume growth in toothpaste and continued dominant market share above 56% Operating Income Raw Material Expenses Raw material cost started softening on account of lower crude prices Employee Expenses SG&A Expenses A&P expenditure increase aided volume growth in toothpaste segment Other operating Expenses EBITDA EBITDA Margin (%) bps bps Operating margins expanded on the back of lower RM cost & overhead expenses Depreciation Interest... NA. NA Other Income PBT before exceptional Exceptional Items... NA. - Tax Outgo PAT Earnings witnessed 18.3% increase on account of healthy margins Key Metrics YoY growth (%) Volume Growth overall bps 5. NA Volume growth recovered to 7% from 5% in Q1FY15 Volume Growth (Toothpastes) NA NA 9. NA NA NA Volume Mkt Share (Toothpaste) 56.7 NA bps bps Continues to expand market share at the expense of No. 2 player Volume Mkt Share (Toothbrush) 42.6 NA bps 42.6 bps Change in estimates FY15E FY16E FY17E ( Crore) Old New % Change Old New % Change New Comments Sales 4,87.1 4, , , We introduce FY17E number expecting a healthy 15% growth in revenues EBITDA EBITDA Margin (%) bps bps 19.9 We expect the company to expand its market share with lower spend on advertisement PAT EPS ( ) Assumptions Current Earlier Comments FY13 FY14 FY15E FY16E FY17E FY15E FY16E Toothpaste Vol. Growth(%) We expect the company to witness 8-1% volume growth, going forward Toothpaste Value Growth(%) Toothbrush Vol. Growth(%) Toothbrush Value Growth(%) Raw Material/Sales % RM cost to soften with commodity prices cooling off Marketing Exp./Sales % A&P spend continues to remain above 18%, going forward ICICI Securities Ltd Retail Equity Research Page 2

3 Company Analysis Sustained market share to keep revenue growth healthy at 15.6% CAGR CPIL has successfully maintained its market leadership in the oral care segment with 56% share by volume (213) in the toothpaste category and 41.5% volume share (213) in the toothbrush category. The nearest competitors in the toothpaste and toothbrush categories are at almost half the share of CPIL with 22.8% (213) and ~28% (213) share by volume, respectively. With the ability to maintain the premium in its market share and comprehensive oral care portfolio, CPIL registered strong revenue growth of 16.5% CAGR (FY8-13). Going ahead, we believe that led by CPIL s strong brand equity it would continue to maintain its dominance in the segment and further boost its revenue growth through increasing presence in rural India. Hence, we expect healthy revenue CAGR of 15.6% in FY14-17E led by ~9% volume CAGR. Exhibit 1: Revenue CAGR to remain healthy at 15.4% (FY14-17E) FY8 FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E Revenues in crore (LHS) Revenue Growth (YoY) in % (RHS) Exhibit 2: CPIL's market share has only strengthened over the years Mar,'12 Jun,'12 Sep,'12 CY12 Mar,'13 Jun,'13 Sep,'13 CY13 April,'14 June,'14 Sept ' 14 Toothpastes - LHS Toothbrush - RHS ICICI Securities Ltd Retail Equity Research Page 3

4 Dominance in oral care continues with sustained market share gains Led by the dominance of CPIL in toothpastes with a presence across premium, popular and mass categories and having SKUs across variants (regular, sensitive, herbal, whitening, gum care, freshness), CPIL s market share in toothpaste has strengthened from 49.4% in CY8 to 56% in CY13. Aided by the strengthening market share, toothpaste revenues (~75% of CPIL s revenues in FY13) and increasing penetration revenues from the segment have grown at a CAGR of 16.9% in FY8-13. Going ahead, we believe that with toothpaste per capita consumption expected to grow at 5.6% CAGR in FY13-23E to ~24 gm by FY23E and Colgate s ability to maintain its market leadership through increasing innovation and distribution, CPIL s toothpaste volume CAGR would remain strong at 9% in FY Further, with new launches both in the premium and economy segments maintaining their pace, we expect CPIL to post value growth of 14.3% CAGR in FY14-17E. Exhibit 3: Toothpaste revenue growth to remain healthy at 14.3 CAGR Exhibit 4: Volume growth to remain healthy at ~9% FY8 FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E FY9 FY1 FY11 FY12 FY13 FY14E FY15E FY16E FY17E Volume Growth Value Growth The decline in toothbrush volume in FY8 was on the back of a significant increase in volume in FY7 led by a promotion offer by the company in FY7. We believe the offer was implemented by the company to de-stock its toothbrush inventory from its Sewri unit. The unit was shut down during that year and the company shifted the manufacturing of toothbrushes capacity to the Baddi unit Strengthening presence in toothbrush to sustain growth at 19.7% CAGR (FY14-17E) CPIL s undeterred market share at 41.5% (CY13) in the toothbrush segment (~11% of revenues in FY13) has been led by strong volume CAGR (FY8-13) of 21.2% and value CAGR of 19.4% (FY8-13). The company s brand strength has enabled it to grab market share of unbranded players. Further, CPIL s nearest competitor, P&G, with brand Oral-B, continues to maintain a distant No.2 position in the segment with ~19% volume share in the segment. We believe that with the upgrading consumer needs in rural markets and uptrading demand by urban consumer, CPIL s revenues from the toothbrush segment would continue to grow at 19.7% CAGR (FY14-17E) led by healthy volume CAGR of 15.8%. We expect CPIL s strong brand equity to aid in further strengthening the market share for the company in the toothbrush segment. Exhibit 5: Toothbrush revenue growth to remain strong at 19.7% CAGR FY8 FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E Exhibit 6: led by volume CAGR of ~16% FY8 FY9 FY1 FY11 FY12 FY13 FY14E FY15E FY16E FY17E -7.9 Volume Growth Value Growth ICICI Securities Ltd Retail Equity Research Page 4

5 Increasing penetration, per capita consumption to aid growth The penetration of toothpaste in India is ~71% (212), with ~35 crore of the population still using conventional methods of brushing. Though urban penetration is higher at ~91% (212), rural penetration lags behind at only 63% (212). Hence, we believe there lies a huge untapped opportunity for CPIL to increase its reach and volumes being the market leader of the segment. Further, the overall per capita consumption of toothpaste in India is significantly lower at 137 gm (212) compared to other developing nations, China at 277 gm, Philippines at 374 gm and Brazil at 622 gm, providing enough room for CPIL to maintain its volume growth. We believe increase in volume growth & per capita consumption would come through increasing awareness on oral hygiene, change in consumer habits (brushing twice daily) and increasing penetration, aiding the company to maintain its healthy volume and value growth. Margins to gain strength on improving mix CPIL s EBITDA margins have improved significantly from 15.4% in FY8 to 2.8% in FY13 led by gross margin expansion and increasing contribution of premium products in revenues. Led by the company s strong brand equity, CPIL enjoys strong pricing power in the oral care industry enabling it to easily pass on higher raw material cost through increasing prices without impacting its volume growth and concurrently expanding its gross margins. Hence, higher gross margins have enabled the company to expand its EBITDA margins. Since Q1FY14, however, CPIL s margins have been witnessing moderation following the increased competitive action in the oral care industry and slowing urban consumption demand (moderating the rate of premiumisation in the segment). The increased competitive activity (HUL s aggressiveness and P&G s re-entry) has pulled up the marketing & other expenditure (includes sales promotion expenses) of CPIL, thereby moderating its margins to 18.6% in FY14. We believe that though high marketing expenses have stressed margins in the near term, they have aided CPIL in maintaining its market share and a healthy volume growth in a tough scenario. The change in portfolio mix aided by higher marketing spends has already improved the margins to 2.2% in Q1FY15. Hence, we believe that as consumption demand revives (driving premiumisation) and CPIL further gains market share in the segment, EBITDA margins would trend back to 19.8% by FY16E &19.9% in FY17E. Exhibit 7: EBITDA margins to improve to 19.9% by FY17E FY8 FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E EBITDA ( crore) - LHS EBITDA Margin (%) - RHS ICICI Securities Ltd Retail Equity Research Page 5

6 Exhibit 8: Marketing expenses to remain high until FY17E Exhibit 9: RM cost to sales ratio to remain low at ~4% until FY17E FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E Marketing Expenses to Sales % Other Expenditure to sales % Raw Material Expenses to Sales % Brand strength to aid in fighting competition CPIL s brand strength has aided in keep competition away and maintaining its strong dominance in toothpaste and toothbrush. However, since H1FY14 (re-entry of P&G and expanding portfolio by Dabur, GSK Consumer, HUL), competition has been getting aggressive targeting the huge untapped opportunity of the segment. This has pulled up CPIL s sales & promotion expenses ~3% YoY pressurising margins (declined from ~21% in FY13 to ~18% in FY14). Though margins have been stressed, CPIL s market share has further strengthened led by CPIL s high brand equity aiding in keeping competition at bay. We believe there could be near term challenges for margins. However, with CPIL s ability to innovate and maintain its dominance, margins would revive. Higher taxes to limit PAT growth Though we believe CPIL s margins would get back to higher levels of ~2% by FY16E, PAT growth is estimated to moderate to 9.8% CAGR (FY14-16E) against 16.5% CAGR (FY8-13). The moderation in earnings growth would be led by higher tax incidence on CPIL s Baddi plant (Himachal Pradesh). CPIL s Baddi plant was under 1% tax exemption until March, 21 and is currently enjoying ~3% tax exemption until FY15, after which it will enjoy no further exemptions. We estimate the effective tax rate for CPIL will increase from 25.8% in FY14 to 3% in FY16E & FY17E, keeping earnings growth of CPIL under check. Exhibit 1: PAT growth to moderate following higher tax incidence FY9 FY1 FY11 FY12 FY13 FY14E FY15E FY16E FY17E PAT ( crore) Tax Rate (% of PBT) ICICI Securities Ltd Retail Equity Research Page 6

7 High dividend payout and strong return ratios CPIL has had exceptional return ratios of more than 1% mainly due to high dividend payout of ~7% and ~ 56 crore of free cash flow in FY13. The free cash flow of CPIL has increased from 38 crore in FY8 to 56 crore in FY13. Return ratios for CPIL have remained on a higher trajectory of ~1% since FY8 following the capital reduction by the company in FY8 and reducing the face value to 1/share from 1/share. This improved the RoE from 57.1% in FY7 to 142.8% in FY8. With no major capex plans lined up by the company, we expect the payout to sustain at ~75% until FY16E, thereby keeping return ratios at healthy levels. The dividend payout dipped slightly in FY14E following CPIL s capex in new facilities in Sanand, Gujarat and Sricity, Andhra Pradesh. However, with the Gujarat plant already in operation from Q1FY15 onwards and no new capex plans ahead, we expect the dividend payout to increase again to ~75% in FY15E. Exhibit 11: Return ratios to remain at elevated levels Exhibit 12: Dividend payout to return to ~75% by FY17E FY9 FY1 FY11 FY12 FY13 FY14E FY15E FY16E FY17E RoCE (%) - LHS RoNW(%) - RHS FY9 FY1 FY11 FY12 FY13 FY14 FY15E FY16E FY17E Dividend Per share ( ) - RHS Dividend Payout (%) - LHS ICICI Securities Ltd Retail Equity Research Page 7

8 Outlook & valuation With Colgate s strengthening presence in toothpastes in spite of fierce competition in the segment, we remain positive on the long term growth driven by increasing per-capita consumption and premiumisation in the segment. The company s unmatched product portfolio would continue to maintain its dominance in the oral care segment. Though there are few near term concerns for margins given the increased competitive intensity in the segment, we believe CPIL s higher marketing spends and strengthening market share would continue to yield positive long term returns for the company. However, we remain wary of the expensive valuations of the company. CPIL is currently trading at 34x its FY16E EPS of 47.9, higher than its historical average P/E of 28x. We value CPIL on triangulated valuation method, assigning 5% weightage to price to sales multiple, 4% weightage to DCF and 1% to EV/EBITDA, arriving at a target price of 1919 per share. We maintain our HOLD recommendation on the stock. Exhibit 13: Valuations Sales Growth EPS Growth PE EV/EBITDA RoNW RoCE ( cr) (%) ( ) (%) (x) (x) (%) (%) FY FY15E FY16E FY17E ICICI Securities Ltd Retail Equity Research Page 8

9 Company snapshot 2, 1,6 Target Price ,2 8 4 Dec-8 Mar-9 Jun-9 Sep-9 Dec-9 Mar-1 Jun-1 Sep-1 Dec-1 Mar-11 Jun-11 Sep-11 Dec-11 Mar-12 Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 Sep-13 Dec-13 Mar-14 Jun-14 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 Dec-15 Mar-16 Jun-16 Sep-16 Source: Bloomberg, Company, ICICIdirect.com Research Key events Date Jul-9 Event Rise in share price aided by a special dividend of 8/share and the increasing attractiveness of the defensives (FMCG Index) following the economic downturn Nov-9 Second interim dividend of 7/share taking the total dividend in H1FY1 to 15/share May-1 The company did not pay any final dividend keeping the dividend per share for FY1 restricted at 2/share Jul-1 First interim dividend for FY11 of 1/share Mar-11 Lacklustre performance of the stock following lower sales growth of ~13% and a decline in margins and net profit following increased competition May-12 Significant jump in performance with reported sales growth of ~21% YoY, volume growth of ~12% and improvement in margins. Also, with a run up in FMCG stocks, following the robust growth and subdued performance in other sectors, the stock price witnessed significant gains Jan-13 Stock gained significantly mirroring the FMCG Index led by the preference of defensives with strong market leadership in a weak economic scenario Jun-13 The re-entry of P&G in the oral care market in the country increased pressure on the stock considering the concerns of increasing competition from a fierce player. Also, following the entry, Colgate's marketing expenses were expected to increase, pressurising margins Nov-13 The concerns on subdued FMCG volume growth with softening consumer demand impacted the performance of the complete FMCG Index also impacting Colgate's stock performance Top 1 Shareholders Rank Name Latest Filing Date % O/S Position (m) Change (m) 1 State Street Global Advisors (US) 3-Jun The Vanguard Group, Inc. 3-Jun Fidelity Management & Research Company 3-Jun BlackRock Institutional Trust Company, N.A. 3-Sep MFS Investment Management 3-Jun Walter Scott & Partners Ltd. 3-Jun Janus Capital Management LLC 3-Jun Renaissance Technologies Corp. 3-Jun Wellington Management Company, LLP 3-Jun State Farm Insurance Companies 3-Jun Source: Reuters, ICICIdirect.com Research Shareholding Pattern (in %) Sep-13 Dec-13 Mar-14 Jun-14 Sep-14 Promoter FII DII Others Recent Activity Buys Sells Investor name Value Shares Investor name Value Shares Renaissance Technologies Corp m 2.26m Lansdowne Partners (UK) LLP m -7.86m GenSpring Family Offices, LLC m 1.98m Independent Franchise Partners LLP m -4.5m The Boston Company Asset Management, LLC m 1.73m Magellan Asset Management Limited m -2.55m Lord, Abbett & Co. LLC 18.38m 1.59m American Century Investment Management, Inc m -2.46m Santa Barbara Asset Management, LLC 91.76m 1.35m Pioneer Investment Management, Inc m -1.84m Source: Reuters, ICICIdirect.com Research ICICI Securities Ltd Retail Equity Research Page 9

10 Financial summary Profit and loss statement Crore (Year-end March) FY14 FY15E FY16E FY17E Total Operating Income Growth (%) Raw Material Expenses 1,42. 1, , ,158.6 Employee Expenses Marketing Expenses Administrative Expenses Other expenses Total Operating Expenditure 2, ,39.2 3, ,394.5 EBITDA ,93. Growth (%) Depreciation Interest.... Other Income PBT ,65.5 Exceptional items Total Tax PAT Growth (%) EPS ( ) Cash flow statement Crore (Year-end March) FY14 FY15E FY16E FY17E Profit/Loss after Tax Add: Depreciation Add: Interest.... (Inc)/dec in Current Assets Inc/(dec) in Current Liabilities CF from operating activities (Inc)/dec in Investments (Inc)/dec in Fixed Assets Others CF from investing activities Issue/(Buy back) of Equity.... Inc/(dec) in loan funds.... Dividend paid & dividend tax Inc/(dec) in Sec. premium.... Others.... CF from financing activities Net Cash flow Opening Cash Closing Cash Balance sheet Crore FY14 FY15E FY16E FY17E Liabilities Equity Capital Reserve and Surplus ,35.4 Total Shareholders funds ,49. Total Debt.... Long Term Provisions Other Non-current Liabilities Total Liabilities ,74.6 Assets Gross Block ,82.7 1, ,182.7 Less: Acc Depreciation Net Block Capital WIP Deferred Tax Asset Non Current Investments LT Loans & Advances/Others Current Assets Inventory Debtors Cash Loans & Advances Other Current Assets Current Liabilities Creditors Provisions Other CL Net Current Assets Total Assets ,74.6 Key ratios (Year-end March) FY14 FY15E FY16E FY17E Per share data ( ) EPS Cash EPS BV DPS Cash Per Share Operating Ratios (%) EBITDA Margin PBT / Net Sales PAT Margin Inventory days Debtor days Creditor days Return Ratios (%) RoE RoCE RoA Valuation Ratios (x) P/E EV / EBITDA EV / Net Sales Market Cap / Sales Price to Book Value Solvency Ratios Debt/EBITDA.... Debt / Equity.... Current Ratio Quick Ratio ICICI Securities Ltd Retail Equity Research Page 1

11 ICICIdirect.com coverage universe (FMCG) CMP M Cap EPS ( ) P/E (x) EV/EBITDA (x) RoCE (%) RoE (%) Sector / Company ( ) TP( ) Rating ( Cr) FY14 FY15E FY16E FY14 FY15E FY16E FY14 FY15E FY16E FY14 FY15E FY16E FY14 FY15E FY16E Colgate (COLPAL) 1,877 1,919 Hold 25, Dabur India (DABIND) Hold 39, Hindustan Unilever (HINLEV) Hold 155, ITC Limited (ITC) Hold 282, Jyothy Lab (JYOLAB) Hold 4, Marico (MARIN) Buy 18, Nestle (NESIND) 6,351 6,123 Hold 59, Tata Global Bev (TATTEA) Buy 9, VST Industries (VSTIND) 1,82 1,872 Hold 2, ICICI Securities Ltd Retail Equity Research Page 11

12 RATING RATIONALE ICICIdirect.com endeavours to provide objective opinions and recommendations. ICICIdirect.com assigns ratings to its stocks according to their notional target price vs. current market price and then categorises them as Strong Buy, Buy, Hold and Sell. The performance horizon is two years unless specified and the notional target price is defined as the analysts' valuation for a stock. Strong Buy: >15%/2% for large caps/midcaps, respectively, with high conviction; Buy: >1%/15% for large caps/midcaps, respectively; Hold: Up to +/-1%; Sell: -1% or more; Pankaj Pandey Head Research pankaj.pandey@icicisecurities.com ICICIdirect.com Research Desk, ICICI Securities Limited, 1st Floor, Akruti Trade Centre, Road No 7, MIDC, Andheri (East) Mumbai 4 93 research@icicidirect.com ANALYST CERTIFICATION We /I, Sanjay Manyal, MBA (Finance); Parineeta Rajgarhia, MBA research analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our personal views about any and all of the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Analysts aren't registered as research analysts by FINRA and might not be an associated person of the ICICI Securities Inc. Disclosures: ICICI Securities Limited (ICICI Securities) and its affiliates are a full-service, integrated investment banking, investment management and brokerage and financing group. We along with affiliates are leading underwriter of securities and participate in virtually all securities trading markets in India. We and our affiliates have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. Our research professionals provide important input into our investment banking and other business selection processes. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their dependent family members from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on reasonable basis, ICICI Securities, its subsidiaries and associated companies, their directors and employees ( ICICI Securities and affiliates ) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities is acting in an advisory capacity to this company, or in certain other circumstances. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return of investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ICICI Securities and its affiliates might have managed or co-managed a public offering for the subject company in the preceding twelve months. ICICI Securities and affiliates might have received compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of public offerings, corporate finance, investment banking or other advisory services in a merger or specific transaction. It is confirmed that Sanjay Manyal, MBA (Finance); Parineeta Rajgarhia, MBA research analysts and the authors of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months. Our research professionals are paid in part based on the profitability of ICICI Securities, which include earnings from Investment Banking and other business. ICICI Securities or its subsidiaries collectively do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report. It is confirmed that Sanjay Manyal, MBA (Finance); Parineeta Rajgarhia, MBA research analysts and the authors of this report or any of their family members does not serve as an officer, director or advisory board member of the companies mentioned in the report. ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. ICICI Securities and affiliates may act upon or make use of information contained in the report prior to the publication thereof. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. ICICI Securities Ltd Retail Equity Research Page 12

Praj Industries (PRAIN)

Praj Industries (PRAIN) Result Update October 18, 211 Rating matrix Rating : Buy Target : 96 Target Period : 12-15 months Potential Upside : 25% WHAT S CHANGED Praj Industries (PRAIN) 77 Key Financials Crore FY1 FY11 FY12E FY13E

More information

Colgate-Palmolive India (COLPAL) 971

Colgate-Palmolive India (COLPAL) 971 Result Update Rating matrix Rating : Hold Target : 971 Target Period : 12 months Potential Upside : % What s changed? Target Changed from 94 to 971 EPS FY17E Changed from 23.5 to 22.1 EPS FY18E Changed

More information

Wabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Wabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research. Management Meet Note Rating matrix Rating : Buy Target : 6750 Target Period : 12 months Potential Upside : 14% What s Changed? Target Changed from 6400 to 6750 EPS FY17E Unchanged EPS FY18E Unchanged Rating

More information

D-Link India (DLILIM) 105

D-Link India (DLILIM) 105 Company Update Rating matrix Rating : Buy Target : 140 Target Period : 18-24 months Potential Upside : 34% What s Changed? Target Changed from 150 to 140 EPS FY18E Changed from 11.4 to 9.5 EPS FY19E Introduced

More information

Wim Plast Ltd (WIMPLA) 1320

Wim Plast Ltd (WIMPLA) 1320 Company Update Rating matrix Rating : Hold Target : 1420 Target Period : 12 months Potential Upside : 8% What s changed? Target Unchanged EPS FY17E Changed from 46.4 to 46.7 EPS FY18E Introduced at 56.1

More information

Colgate-Palmolive India (COLPAL) 1080

Colgate-Palmolive India (COLPAL) 1080 Result Update Rating matrix Rating : Hold Target : 115 Target Period : 12 months Potential Upside : 7% What s changed? Target EPS FY18E EBS FY19E Rating Quarterly performance Unchanged Unchanged Unchanged

More information

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017 Sector Update Sectoral View Cement Positive Rating matrix Companies Rating Target Price Old Revised Old Revised Shree Cement Hold Hold 19700 19000 JK Lakshmi Cement Buy Buy 495 470 Mangalam Cement Buy

More information

Reliance Capital (RELCAP)

Reliance Capital (RELCAP) Event Update Rating matrix Rating : Buy Target : 466 Target Period : 12 months Potential Upside : 41% Key Financials (Consolidated) crore FY10 FY11 FY12E FY13E Revenues 6141 5499 6452 7129 PBT 592 287.3

More information

Colgate-Palmolive India (COLPAL) 994

Colgate-Palmolive India (COLPAL) 994 Result Update Rating matrix Rating : Hold Target : 99 Target Period : 12 months Potential Upside : % What s changed? Target Changed from 95 to 99 EPS FY18E Changed from 23.4 to 23.6 EBS FY19E Changed from

More information

Emmbi Industries (EMMPOL)

Emmbi Industries (EMMPOL) Management Meet Note Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore Net Sales 2.2 139.7 157.9 182.6 EBITDA 9.8 12.6 15.3 19.7 Net Profit 3.3 3.2

More information

Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. RESULT UPDATE 5th February, 2018 Feb-15 Aug-15 Feb-16 Aug-16 Feb-17 Aug-17 Feb-18 India Equity Institutional Research II Result Update - Q3FY18 II 5th February, 2018 CMP INR 1,120 MARKET DATA Target INR

More information

Bajaj Finserv (BAFINS) 5443

Bajaj Finserv (BAFINS) 5443 Aug-17 Jun-17 Apr-17 Feb-17 Dec-16 Oct-16 Aug-16 May-16 Mar-16 Jan-16 Nov-15 Sep-15 Company Update Rating matrix Rating Buy Target 6000 Target Period 12 months Potential Upside 10% What s Changed? Target

More information

Singer India (SININ) Focus on tapping small appliances segment. Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Singer India (SININ) Focus on tapping small appliances segment. Management Meet Note. ICICI Securities Ltd Retail Equity Research. Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore Revenues 118.9 155.9 196.9 243.4 285. 239.4 EBITDA.6 7.9 6.4 8.6 8.2 8. Net

More information

I Direct. nstinct. September 19, 2017

I Direct. nstinct. September 19, 2017 I Direct nstinct September 19, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on

More information

Lumax Industries (LUMIND)

Lumax Industries (LUMIND) Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore FY14 FY15 FY16 FY17 Net Sales 1,117 1,143 1,255 1,300 EBITDA 51 59 89 100 Net

More information

Bajaj Finserv (BAFINS) 4375

Bajaj Finserv (BAFINS) 4375 Company Update Rating matrix Rating Buy Target 4900 Target Period 12 months Potential Upside 12% What s Changed? Target Changed from 3620 to 4900 EPS FY17E Changed from 146.2 to 150.3 EPS FY18E Changed

More information

I Direct. nstinct. November 27, 2017

I Direct. nstinct. November 27, 2017 I Direct nstinct November 27, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Union Bank of India (UNIBAN)

Union Bank of India (UNIBAN) Result Update Rating matrix Rating : Hold Target : 22 Target Period : 12 months Potential Upside : 5 % Key Financials crore FY1 NII 4192 6216 714 8312 PPP 3659 435 496 552 PAT 275 282 1915 2439 Valuation

More information

GE Shipping (GESHIP) Striking valuation. Result Update. Rs 262 WHAT S CHANGED. Valuation. February 8, Rating matrix.

GE Shipping (GESHIP) Striking valuation. Result Update. Rs 262 WHAT S CHANGED. Valuation. February 8, Rating matrix. Result Update Rating matrix Rating : Strong Buy Target : Rs 37 Target Period : 1 months Potential Upside : 4% Key Financials (Rs Crore) FY9 FY1E FY11E FY1E Net Sales 3. 3. 3379.9 33. EBITDA 166.1 916.4

More information

Graphite Electrodes. Good times to continue... Sector Update. ICICI Securities Ltd Retail Equity Research. January 3, 2018

Graphite Electrodes. Good times to continue... Sector Update. ICICI Securities Ltd Retail Equity Research. January 3, 2018 Sector Update Rating Matrix Company Target Price CMP Upside Rating Graphite India 1, 84 19% Buy HEG 32 265 21% Buy Target period is 15-18 months Price performance (%) Return % 1M 3M 6M 12M HEG 49.7 173.7

More information

Hindustan Unilever (HINLEV) 868

Hindustan Unilever (HINLEV) 868 Result Update May 11, 215 Rating matrix Rating : Hold Target : 92 Target Period : 12 months Potential Upside : 4% What s changed? Target EPS FY16E EPS FY17E Rating Unchanged Unchanged Unchanged Unchanged

More information

Monte Carlo Fashions (MONCAR) 580

Monte Carlo Fashions (MONCAR) 580 Analyst Meet Note December 13, 217 Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials ( Crore) FY14 FY15 FY16 FY17 Net Sales 53.1 582.6 621.5 584.1 EBITDA

More information

I Direct. nstinct. February 7, 2018

I Direct. nstinct. February 7, 2018 I Direct nstinct February 7, 2018 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Bajaj Finance (BAJAF) 5498

Bajaj Finance (BAJAF) 5498 Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore FY12 FY13 FY14 FY15 NII 1,25 1,717 2,215 2,872 PPP 756 1,53 1,349 1,742 PAT

More information

Bajaj Finserv (BAFINS) 3130

Bajaj Finserv (BAFINS) 3130 Company Update Rating matrix Rating Buy Target 3470 Target Period 12 months Potential Upside 11% What s Changed? Target Changed from 2900 to 3470 EPS FY17E EPS FY18E EPS FY19E Introducing at 242.3 Rating

More information

UltraTech Cement (ULTCEM)

UltraTech Cement (ULTCEM) April 20, 2009 Cement Company Update UltraTech Cement (ULTCEM) Current Price Rs 546 Potential upside 15.4% Target Price Rs 630 Time Frame 12-15 months Powered by savings Historically, UltraTech Cement

More information

KPIT Cummins Infosystems (KPISYS)

KPIT Cummins Infosystems (KPISYS) Result Update Rating matrix Rating : Hold Target : 110 Target Period : 12 months Potential Upside : 6% Key Financials ( Crore) FY12 FY13E FY14E FY15E Net Sales 1500 2239 2517 2876 EBITDA 218 365 423 472

More information

I Direct. nstinct. January 4, 2018

I Direct. nstinct. January 4, 2018 I Direct nstinct January 4, 2018 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Nestlé India (NESIND) 6331

Nestlé India (NESIND) 6331 Result Update Rating matrix Rating : Hold Target : 64 Target Period : 12- months Potential Upside : -% What s changed? Target Unchanged EPS CYE Changed from 121.9 to 4.9 EPS CY16E Changed from 134.2 to

More information

Prabhat Dairy (PRADAI) 184

Prabhat Dairy (PRADAI) 184 Result Update Rating matrix Rating : Buy Target : 215 Target Period : 12 months Potential Upside : 17% What s changed? Target Changed from 165 to 215 EPS FY19E Unchanged EPS FY20E Introduced at 9.5 Rating

More information

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

IndusInd Bank (INDBA) 1717

IndusInd Bank (INDBA) 1717 Event Update Rating matrix Rating : Buy Target : 1920 Target Period : 12 months Potential Upside : 12% What s Changed? Target EPS FY18E EPS FY19E Rating Price chart October 16, 2017 IndusInd Bank (INDBA)

More information

Star Ferro & Cement (STAFER) 113

Star Ferro & Cement (STAFER) 113 Result Update Rating Matrix Rating : Buy Target : 132 Target Period : 12-15 months Potential Upside : 17% What s Changed? Target Changed from 135 to 132 EPS FY17E Changed from 6.4 to 5.9 EPS FY18E Changed

More information

Schaeffler India (FAGBEA) 4800

Schaeffler India (FAGBEA) 4800 Event update Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Stock Data Particular Amount Market Capitalization ( crore) 7,968 Net Debt (CY16) ( crore) (640.6) Net Worth

More information

Reliance Capital (RELCAP) 549

Reliance Capital (RELCAP) 549 Company Update Rating matrix Rating Buy Target 718 Target Period 12 months Potential Upside 31% Key Financials crore FY16E FY17E FY18E FY19E Revenues 9998 16776 18727 21501 PBT 1733 1459 1974 2560 Adjusted

More information

Varun Beverages (VARBEV) 481

Varun Beverages (VARBEV) 481 Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key financials (consolidated) Crore CY12 CY13 CY14 CY15 CY16 Net sales 1,8. 2,115.1 2,52.4 3,394.1

More information

I Direct. nstinct. March 27, 2018

I Direct. nstinct. March 27, 2018 I Direct nstinct March 27, 2018 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

ITC Ltd (ITC) 272. Non-cigarettes business profitability perks up. Result Update. ICICI Securities Ltd Retail Equity Research.

ITC Ltd (ITC) 272. Non-cigarettes business profitability perks up. Result Update. ICICI Securities Ltd Retail Equity Research. Result Update Rating matrix Rating : Buy Target : 32 Target Period : 12 months Potential Upside : 18% What s changed? Target Unchanged EPS FY19E Changed from 8.6 to 9.9 EPS FY2E Introduced at 1.8 Rating

More information

PC Jeweller (PCJEW) 417 Stepping up store expansion via small store s. Management Meet Note. ICICI Securities Ltd Retail Equity Research

PC Jeweller (PCJEW) 417 Stepping up store expansion via small store s. Management Meet Note. ICICI Securities Ltd Retail Equity Research Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials ( Crore) Net Sales 4,018.4 5,324.8 6,361.3 7,330.2 EBITDA 481.8 587.7 730.2 731.5

More information

ITC Ltd. RESULT UPDATE 27th October, 2017

ITC Ltd. RESULT UPDATE 27th October, 2017 . RESULT UPDATE 27th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside

More information

Hindustan Unilever (HINLEV) 919

Hindustan Unilever (HINLEV) 919 Result Update Rating matrix Rating : Buy Target : 117 Target Period : 12 months Potential Upside : 11% What s changed? Target Changed from 92 to 117 EPS FY16E Changed from 2.8 to 21.2 EPS FY17E Changed

More information

Hindustan Unilever (HINLEV) 789

Hindustan Unilever (HINLEV) 789 Result Update Rating matrix Rating : Buy Target : 117 Target Period : 12 months Potential Upside : 29% What s changed? Target Unchanged EPS FY16E Changed from 21. to 2.8 EPS FY17E Changed from 2.9 to 24.8

More information

ITC Ltd (ITC) 285. GST woes recede; volume growth to recover. Result Update. ICICI Securities Ltd Retail Equity Research.

ITC Ltd (ITC) 285. GST woes recede; volume growth to recover. Result Update. ICICI Securities Ltd Retail Equity Research. Result Update Rating matrix Rating : Buy Target : 33 Target Period : 12 months Potential Upside : 15% What s changed? Target Changed from 32 to 33 EPS FY19E Changed from 9.9 to 1.2 EPS FY2E Changed from

More information

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017 Company Update Rating matrix Rating : Hold Target : 200 Target Period : 12 months Potential Upside : -4% What s Changed? Target Changed from 165 to 200 EPS FY18E EPS FY19E Rating Key Financials Crore FY16

More information

Hotel Leela (HOTLEE) 22

Hotel Leela (HOTLEE) 22 Result Update Rating matrix Rating : Drop Coverage Target : NA Target Period : NA Potential Upside : NA What s Changed? Target EPS FY15E EPS FY16E Rating NA Unchanged Unchanged Changed from Sell to Drop

More information

Simplex Infrastructure (SIMCON)

Simplex Infrastructure (SIMCON) Result Update Rating matrix Rating : Buy Target : 331 Target Period : 12-15 months Potential Upside : 42% Key Financials crore FY10 FY11E FY12E FY13E Net sales 4443.5 4749.7 5812.3 6867.0 EBITDA 433.7

More information

I Direct. nstinct. July 10, 2017

I Direct. nstinct. July 10, 2017 I Direct nstinct July 10, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Graphite India (CAREVE) 110

Graphite India (CAREVE) 110 Result Update Rating matrix Rating : Hold Target : 15 Target Period : 12 months Potential Upside : -5% What s Changed? Target Changed from 1 to 15 EPS FY18E Changed from 5.5 to 5.4 EPS FY19E Changed from

More information

Nestle India Ltd. RESULT UPDATE

Nestle India Ltd. RESULT UPDATE RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside

More information

Taj GVK Hotels (TAJGVK) 167

Taj GVK Hotels (TAJGVK) 167 Result Update Rating matrix Rating : Buy Target : 195 Target Period : 12- months Potential Upside : % What s Changed? Target Changed from 190 to 195 EPS FY18E Changed from 1.5 to 2.0 EPS FY19E Changed

More information

Graphite India (CAREVE) 75

Graphite India (CAREVE) 75 Result Update Rating matrix Rating : Buy Target : 85 Target Period : 12 months Potential Upside : 13% What s Changed? Target Changed from 90 to 85 EPS FY16E Changed from 4.8 to 5.4 EPS FY17E Changed from

More information

Biocon (BIOCON) Back on track. Result Update WHAT S CHANGED. ICICI Securities Ltd Retail Equity Research. October 21, 2011

Biocon (BIOCON) Back on track. Result Update WHAT S CHANGED. ICICI Securities Ltd Retail Equity Research. October 21, 2011 Result Update Rating matrix Rating : Buy Target : 432 Target Period : 12-15 months Potential Upside : 24 % Key Financials ( Crore) FY10 FY11 FY12E FY13E Net Sales 2368 2770 2230 2670 EBITDA 471 592 646

More information

Mayur Uniquoters (MAYUNI)

Mayur Uniquoters (MAYUNI) Management Meet Note Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials ( Crore) FY12 FY13 FY14 FY15 Net Sales 317.4 38.5 469.6 6.3 EBITDA 53.3 69.1 93.2

More information

Reliance Housing Finance

Reliance Housing Finance Sep-17 Jun-17 Apr-17 Feb-17 Dec-16 Oct-16 Aug-16 Jun-16 Apr-16 Jan-16 Nov-15 Sep-15 Management Meet Rating matrix (Reliance Housing Finance) Rating Listing 115-120 Target Period Potential Upside Key financials

More information

State Bank of India (STABAN) 335

State Bank of India (STABAN) 335 [ [ Company Update Rating matrix Rating : Buy Target : 390 Target Period : 12 months Potential Upside : 16% Valuation summary (merged bank) FY18E FY19E P/E 31.6 20.5 Target P/E 36.7 23.9 P/ABV 2.2 2.0

More information

Nestlé India (NESIND) 6178

Nestlé India (NESIND) 6178 Result Update Rating matrix Rating : Buy Target : 724 Target Period : 12-1 months Potential Upside : 17% What s changed? Target Unchanged EPS CY1E Changed from 4.3 to 4.9 EPS CY16E Changed from 116. to

More information

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018 RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP

More information

Bodal Chemicals (BODCHE)

Bodal Chemicals (BODCHE) Management Meet Note Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials ( Crore) Net Sales 527.5 959.5 1,045.3 910.0 EBITDA 19.8 115.1 184.1 156.6 Net Profit

More information

Nestlé India (NESIND) 6603

Nestlé India (NESIND) 6603 Management Meet Note Rating matrix Rating : Buy Target : 76 Target Period : 12-15 months Potential Upside : 15% What s changed? Target EPS CY17E EPS CY18E Rating Unchanged Unchanged Unchanged Unchanged

More information

Graphite India (CAREVE) 75

Graphite India (CAREVE) 75 Result Update Rating matrix Rating : Buy Target : 90 Target Period : 12 months Potential Upside : 20% What s Changed? Target Changed from 94 to 90 EPS FY16E Changed from 6.5 to 4.8 EPS FY17E Changed from

More information

Bank of Baroda (BANBAR) 156

Bank of Baroda (BANBAR) 156 [ Jun-16 Aug-16 Oct-16 Nov-16 Jan-17 Mar-17 Apr-17 Jun-17 Management Meet Note Rating matrix Rating : Buy Target : 200 Target Period : 12 months Potential Upside : 28% What s changed? Target Unchanged

More information

Graphite India (CAREVE) 454

Graphite India (CAREVE) 454 Result Update Rating matrix Rating : Buy Target : 550 Target Period : 15-18 months Potential Upside : 21% What s Changed? Target Changed from 350 to 550 EPS FY18E Changed from 11.1 to 15.4 EPS FY19E Changed

More information

Graphite India (CAREVE) 82

Graphite India (CAREVE) 82 Result Update Rating matrix Rating : Buy Target : 94 Target Period : 12 months Potential Upside : 15% What s Changed? Target Changed from 105 to 94 EPS FY16E Changed from 7.4 to 6.5 EPS FY17E Changed from

More information

Siyaram Silk Mills (SIYSIL) 575

Siyaram Silk Mills (SIYSIL) 575 Result Update Rating matrix Rating : Buy Target : 655 Target Period : 12 months Potential Upside : 15% What s changed? Target Changed from 620 to 655 EPS FY18E Changed from 21.8 to 22.0 EPS FY19E Changed

More information

Power Finance Corporation Floor Price 254

Power Finance Corporation Floor Price 254 Offer for Sale Note View Rating: Unrated Issue Details Auction Date Issue Size No of Shares on offer Fresh Issue *Based on offer price on 25 July 2015 July 27, 2015 1676 crore* 6.6 crore Nil Shareholding

More information

Stock Trader: ONGC. Research Analysts.

Stock Trader: ONGC. Research Analysts. Research Analysts Amit Gupta Raj Deepak Singh Azeem Ahmad Stock Trader: ONGC amit.gup@icicisecurities.com rajdeepak.singh@icicisecurities.com azeem.ahmad@icicisecurities.com December 3, 2014 Important

More information

Bharti Airtel (BHATE) 369

Bharti Airtel (BHATE) 369 Event Update Rating matrix Rating : Buy Target : 410 Target Period : 12 months Potential Upside : 11% Whats Changed? Target Unchanged EPS FY18E Unchanged EPS FY19E Unchanged Rating Unchanged Key Financials

More information

Kewal Kiran Clothing (KEWKIR) 1800

Kewal Kiran Clothing (KEWKIR) 1800 Result Update Rating matrix Rating : Hold Target : 1844 Target Period : 12 months Potential Upside : 2% What s changed? Target Unchanged EPS FY18E Changed from 63.4 to 65.9 EPS FY19E Unchanged Rating Unchanged

More information

MPS (MACIN) 740. Uncomplicated. anagement Meet Note. ICICI Securities Ltd Retail Equity Research. December 16, 2014

MPS (MACIN) 740. Uncomplicated. anagement Meet Note. ICICI Securities Ltd Retail Equity Research. December 16, 2014 anagement Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore CY1 FY12 FY13 FY14 Net Sales 127.4 191. 164. 197.3 EBITDA (11.5) 19.8 42.9 63.

More information

Britannia Industries Ltd.

Britannia Industries Ltd. . RESULT UPDATE 30th May, 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 30 th May, 2017 2 Growth Path ahead CMP INR 3419 Target

More information

Hindustan Unilever Ltd.

Hindustan Unilever Ltd. . RESULT UPDATE 18 th July 2017 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 125 105 India Equity Institutional Research II Result Update - FY18 II 18th July, 2017 CMP INR 1158 Target INR 1206 MARKET

More information

Stock Trader: Budget Beneficiary Stock Larsen & Toubro

Stock Trader: Budget Beneficiary Stock Larsen & Toubro Stock Trader: Budget Beneficiary Stock Larsen & Toubro Amit Gupta Raj Deepak Singh Azeem Ahmad amit.gup@icicisecurities.com rajdeepak.singh@icicisecurities.com azeem.ahmad@icicisecurities.com February

More information

Dabur India (DABIND) 355

Dabur India (DABIND) 355 Rating matrix Rating : Buy Target : 390 Target Period : 12 months Potential Upside : 10% What s changed? Target Changed from 375 to 390 EPS FY19E Changed from 8.9 to 8.5 EPS FY20E Introduced at 9.7 Rating

More information

Power Grid Corporation (POWGRI) 132

Power Grid Corporation (POWGRI) 132 Result Update Rating matrix Rating Buy Target 173 Target Period 12 months Potential Upside 21% January 29, 216 Power Grid Corporation (POWGRI) 132 Robust numbers on highest ever capitalisation What s Changed?

More information

NHPC (NHPC) 30. Capacity addition below estimates. Result Update. ICICI Securities Ltd Retail Equity Research. June 5, 2017

NHPC (NHPC) 30. Capacity addition below estimates. Result Update. ICICI Securities Ltd Retail Equity Research. June 5, 2017 Result Update Rating matrix Rating : Hold Target : 32 Target Period : 12 months Potential Upside : 5% What s Changed? Target Unchanged EPS FY18E Changed from 2.4 to 2.3 EPS FY19E Introduced at 2.5 Rating

More information

Ahluwalia Contracts (India)

Ahluwalia Contracts (India) May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted

More information

Britannia Industries Ltd.

Britannia Industries Ltd. . RESULT UPDATE 9th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Saregama India (GRACOM) 315

Saregama India (GRACOM) 315 Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key financials Crore Net Sales 16.8 186. 177.5 186.5 EBITDA 19.9 12.6 17.4 1.5 Net Profit 1. 9.3

More information

Vardhman Textiles (MAHSPI) 990

Vardhman Textiles (MAHSPI) 990 Result Update Rating matrix Rating : Buy Target : 1100 Target Period : 12 months Potential Upside : 11% What s changed? Target Changed from 910 to 1100 EPS FY17E Changed from 129.3 to 144.2 EPS FY18E Changed

More information

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017 RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Graphite India (CAREVE) 74

Graphite India (CAREVE) 74 es Result Update August 11, 216 Rating matrix Rating : Hold Target : 75 Target Period : 12 months Potential Upside : 1% What s Changed? Target Changed from 8 to 75 EPS FY17E Changed from 3.6 to 3.5 EPS

More information

Mahanagar Gas (MAHGAS) 985

Mahanagar Gas (MAHGAS) 985 Result Update Rating matrix Rating : Buy Target : 1085 Target Period : 12 months Potential Upside : 10% What s changed? Target Changed from 1055 to 1085 EPS FY18E Changed from 45.4 to 45.3 EPS FY19E Changed

More information

JK Lakshmi Cement (JKCORP) 374

JK Lakshmi Cement (JKCORP) 374 Result Update Rating matrix Rating : Buy Target : 458 Target Period : 12-15 months Potential Upside : 23% What s changed? Target Changed from 423 to 458 EPS FY15E Changed from 13.2 to 14.6 EPS FY16E Unchanged

More information

Dabur India (DABIND) 275

Dabur India (DABIND) 275 Rating matrix Rating : Buy Target : 304 Target Period : 12 months Potential Upside : 11% What s changed? Target Changed from 283 to 304 EPS FY17E Changed from 7.5 to 7.9 EPS FY18E Changed from 8.1 to 8.6

More information

Hindustan Unilever (HINLEV) 862

Hindustan Unilever (HINLEV) 862 Result Update Rating matrix Rating : Buy Target : 1 Target Period : 12 months Potential Upside : 16% What s changed? Target Unchanged EPS FY17E Changed from 23.2 to 22.1 EPS FY18E Changed from 26.7 to

More information

Stock Trader - Power Grid

Stock Trader - Power Grid Stock Trader - Power Grid Research Analysts: Amit Gupta Raj Deepak Singh Azeem Ahmad amit.gup@icicisecurities.com rajdeepak.singh@icicisecurities.com azeem.ahmad@icicisecurities.com ahmad@icicisec com

More information

Oriental Carbon & Chemicals (ORICAR) 950

Oriental Carbon & Chemicals (ORICAR) 950 Company Update Rating matrix Rating : Buy Target : 1125 Target Period : 12-18 months Potential Upside : 18% What s changed? Target Unchanged at 1125 EPS FY18E Changed from 6.6 to 6.8 EPS FY19E Changed

More information

Dabur India (DABIND) 304

Dabur India (DABIND) 304 Rating matrix Rating : Buy Target : 338 Target Period : 12 months Potential Upside : 11% What s changed? Target Changed from 304 to 338 EPS FY17E Changed from 7.9 to 8.0 EPS FY18E Changed from 8.6 to 9.4

More information

Hindustan Unilever (RHS)

Hindustan Unilever (RHS) Jul-14 Aug-14 Oct-14 Nov-14 Dec-14 Feb-15 Mar-15 Apr-15 Jun-15 Jul-15 India Research FMCG July 22, 2015 QUARTERLY REVIEW Bloomberg: HUVR IN Reuters: HLL.BO SELL Higher A&P drove volume growth HUL s Q1FY16

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Stock Trader - Canara Bank: Focus on Budget

Stock Trader - Canara Bank: Focus on Budget Stock Trader - Canara Bank: Focus on Budget Amit Gupta Raj Deepak Singh Azeem Ahmad amit.gup@icicisecurities.com rajdeepak.singh@icicisecurities.com azeem.ahmad@icicisecurities.com January 20, 2015 Important

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Arbitrage Opportunity in Wipro buyback

Arbitrage Opportunity in Wipro buyback July 21, 2017 Arbitrage Opportunity in Wipro buyback Research Analyst Amit Gupta Raj Deepak Singh amit.gup@icicisecurities.com rajdeepak.singh@icicisecurities.com Arbitrage opportunity in Wipro buy back

More information

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD Colgate-Palmolive Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,063 Recommendation: HOLD Market Statistics Current stock price (`) 1,063 Shares O/S (cr.) 27.2

More information

Quant Pick: Punjab National Bank

Quant Pick: Punjab National Bank July 6, 2017 Quant Pick: Punjab National Bank Quant Pick Stock Action Initiation Range Target Stoploss Time Frame Punjab National Bank Buy 139-142 167 126 3 months Research Analyst Amit Gupta amit.gup@icicisecurities.com

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

I Direct. nstinct. July 13, 2017

I Direct. nstinct. July 13, 2017 I Direct nstinct July 13, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD Colgate-Palmolive Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,083 Recommendation: HOLD Market Statistics Current stock price (`) 1,083 Shares O/S (cr.) 27.2

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information